Cromolyn sodium (disodium cromoglycate).
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000818:Animals; D001249:Asthma / Q000188:drug therapy*; D001285:Atropine; D001980:Bronchi / Q000187:drug effects; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002867:Chromones / Q000627:therapeutic use*; D004205:Cromolyn Sodium / Q000627:therapeutic use; D006636:Histamine Release; D006801:Humans; D007073:Immunoglobulin E; D007136:Immunoglobulins; D009130:Muscle, Smooth / Q000187:drug effects; D005082:Physical Exertion; D051381:Rats; D012119:Respiration; D012138:Respiratory Therapy; D012882:Skin Tests; D013147:Spirometry; D013997:Time Factors
D000317:Adrenergic alpha-Antagonists; D001993:Bronchodilator Agents; D002867:Chromones; D007136:Immunoglobulins; D007073:Immunoglobulin E; D001285:Atropine; D004205:Cromolyn Sodium